1. Home
  2. KVHI vs IPHA Comparison

KVHI vs IPHA Comparison

Compare KVHI & IPHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

HOLD

Current Price

$9.09

Market Cap

188.0M

Sector

Technology

ML Signal

HOLD

Logo Innate Pharma S.A. ADS

IPHA

Innate Pharma S.A. ADS

N/A

Current Price

$1.80

Market Cap

189.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
IPHA
Founded
1978
1999
Country
United States
France
Employees
N/A
163
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
188.0M
189.5M
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
KVHI
IPHA
Price
$9.09
$1.80
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.75
AVG Volume (30 Days)
341.2K
9.5K
Earning Date
05-07-2026
03-26-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
N/A
EPS
0.03
N/A
Revenue
$9,622,000.00
N/A
Revenue This Year
$28.90
$180.36
Revenue Next Year
$31.85
N/A
P/E Ratio
$294.83
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$1.18
52 Week High
$13.00
$2.63

Technical Indicators

Market Signals
Indicator
KVHI
IPHA
Relative Strength Index (RSI) 48.69 52.73
Support Level $8.80 $1.73
Resistance Level $9.71 $1.97
Average True Range (ATR) 0.72 0.09
MACD 0.06 -0.01
Stochastic Oscillator 55.84 36.80

Price Performance

Historical Comparison
KVHI
IPHA

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About IPHA Innate Pharma S.A. ADS

Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. The company's approach includes therapeutic modalities such as monoclonal antibodies, multispecific NK cell engagers through its ANKET platform, and antibody-drug conjugates (ADC). Its portfolio includes lacutamab, which is being studied for cutaneous T-cell lymphomas and peripheral T-cell lymphomas, and monalizumab, which is being developed in collaboration with AstraZeneca for non-small cell lung cancer. The company's revenue mainly consists of revenues from collaboration and licensing agreements and government financing for research expenditure in the form of research tax credits, as well as other grants.

Share on Social Networks: